| |
| | | PISTOIA ALLIANCE AI COE WEBINAR: AI & ML IN DRUG DESIGN | | Creating novel drugs is an extraordinarily hard and complex problem. One of the many challenges in drug design is the sheer size of the search space for novel chemical compounds. Scientists need to find molecules that are active toward a biological target or pathway and at the same time ha... | | |
| | | STREAMLINING IRB SUBMISSIONS TO ACCELERATE CLINICAL TRIALS | | Numerous factors adversely impact the initiation of clinical trials and their efficiency in an industry plagued by rising development costs and increasing complexities. Complex protocols, finding patients who meet challenging inclusion/exclusion criteria, protocol amendments, competition f... | | |
| | | OMICS ANALYSIS FOR BRAIN DISORDERS | | Progress towards the development of effective therapies for brain disorders is held back by a lack of understanding of pathological mechanisms. However, our understanding has been vastly improved by recent advances in systems biology: genomics, epigenomics, transcriptomics, proteomics, and... | | |
| | | DRUG MANUFACTURING ANALYTICS – MAKING THE COMPLEX SIMPLE | | Typically, Manufacturing Operations and Support Personnel spend too much time trying to navigate a complex information landscape to locate data, extract it and combine it with data from other systems to gain insights about the assets and drug manufacturing processes they support and servic... | | |
| |